Altitude Crest Partners Inc. In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 14, 2024), Altitude Crest Partners Inc. reported 29 stock positions worth $233.6 million . Its top holding was Legend Biotech Corp.-ADR (LEGN) at 15.7% of the portfolio, followed by Danaher (DHR, 11.6% ) and Bridgebio Pharma (BBIO, 8.1% ). Compared with Q4 2023, it opened 22 new positions, sold out of 4, added to 2 and reduced 4. The biggest buy was a new position in Stevanato Group SPA (STVN) and the biggest sale Bridgebio Pharma (BBIO, shares −19% ).
Location Stamford, CT
CIK 0001986035
Portfolio Value $233.6M (Q1 2024) Holdings 29 stocks · $233.6M Holdings quarter Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q4 2023 LEGN Legend Biotech Corp.-ADR 652,732 $36.6M Add +20.5% DHR Danaher Corp. 108,700 $27.1M Reduce -10.6% BBIO Bridgebio Pharma Inc. 612,060 $18.9M Reduce -18.9% STVN Stevanato Group SPA 550,000 $17.7M New APLS Apellis Pharmaceuticals Inc. 287,277 $16.9M Add +88.8% TMO Thermo Fisher Scientific Inc. 18,400 $10.7M New AVBP Arrivent Biopharma Inc. 555,555 $9.9M New GPCR Structure Therapeutics Inc. 205,166 $8.8M New KNSA Kiniksa Pharmaceuticals Ltd. 400,441 $7.9M Reduce -12.2% JANX Janux Therapeutics Inc. 193,300 $7.3M New LLY Eli Lilly & Co. 9,200 $7.2M New BHVN Biohaven Ltd. 118,380 $6.5M New IMNM Immunome Inc. 262,284 $6.5M New SWTX Springworks Therapeutics Inc. 128,842 $6.3M New GERN Geron Corp. 1,531,400 $5.1M New ICLR Icon PLC 14,800 $5.0M New MRUS Merus NV 109,837 $4.9M New ROIV Roivant Sciences Ltd. 454,766 $4.8M Reduce -43.7% DNLI Denali Therapeutics Inc. 209,613 $4.3M New CRBP Corbus Pharmaceuticals Holdi 103,703 $4.1M New AGIO Agios Pharmaceuticals Inc. 113,100 $3.3M New DAWN Day One Biopharmaceuticals I 195,497 $3.2M New ALGS Aligos Therapeutics Inc. 2,844,681 $2.8M No change ENGN Engene Holdings Inc. 120,289 $2.0M New APLT Applied Therapeutics Inc. 259,700 $1.8M New ZYME Zymeworks Inc. 145,581 $1.5M New MGX Metagenomi Therapeutics Inc. 133,333 $1.4M New TRML Tourmaline Bio Inc. 47,400 $1.1M New ALNY Alnylam Pharmaceuticals Inc. 200 $30K New
Other holdings (1): bonds, preferreds, convertibles and warrants · $12K (not counted above) Security Class Shares / Principal Value Change SRZNW Surrozen Inc.-CW25 *W EXP 08/01/203 384,573 $12K No change
Total filed on the 13F, all lines: $233.6M.
Portfolio Sells Q4 2023 → Q1 2024 Portfolio Sells quarter Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2023 % Of Portfolio Change To Portfolio ▲ BBIO Bridgebio Pharma Inc. Reduce -18.9% 8.10% −12.28 ARGX Argenx SE - ADR Sold out 0.00% −7.51 BMRN Biomarin Pharmaceutical Inc. Sold out 0.00% −7.36 DHR Danaher Corp. Reduce -10.6% 11.62% −7.20 EXAS Exact Sciences Corp. Sold out 0.00% −4.91 ROIV Roivant Sciences Ltd. Reduce -43.7% 2.05% −4.02 KNSA Kiniksa Pharmaceuticals Ltd. Reduce -12.2% 3.38% −1.97 AMAM New Ambrx Biopharma Inc. Sold out 0.00% −0.41
Portfolio Buys Q4 2023 → Q1 2024 Portfolio Buys quarter Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2023 % Of Portfolio Change To Portfolio ▼ STVN Stevanato Group SPA New 7.56% +7.56 TMO Thermo Fisher Scientific Inc. New 4.58% +4.58 AVBP Arrivent Biopharma Inc. New 4.25% +4.25 GPCR Structure Therapeutics Inc. New 3.76% +3.76 JANX Janux Therapeutics Inc. New 3.12% +3.12 LLY Eli Lilly & Co. New 3.06% +3.06 BHVN Biohaven Ltd. New 2.77% +2.77 IMNM Immunome Inc. New 2.77% +2.77 SWTX Springworks Therapeutics Inc. New 2.71% +2.71 GERN Geron Corp. New 2.16% +2.16 ICLR Icon PLC New 2.13% +2.13 MRUS Merus NV New 2.12% +2.12 DNLI Denali Therapeutics Inc. New 1.84% +1.84 CRBP Corbus Pharmaceuticals Holdi New 1.74% +1.74 AGIO Agios Pharmaceuticals Inc. New 1.42% +1.42 DAWN Day One Biopharmaceuticals I New 1.38% +1.38 APLS Apellis Pharmaceuticals Inc. Add +88.8% 7.23% +1.13 ENGN Engene Holdings Inc. New 0.87% +0.87 APLT Applied Therapeutics Inc. New 0.76% +0.76 ZYME Zymeworks Inc. New 0.66% +0.66 MGX Metagenomi Therapeutics Inc. New 0.60% +0.60 TRML Tourmaline Bio Inc. New 0.46% +0.46 ALNY Alnylam Pharmaceuticals Inc. New 0.01% +0.01 LEGN Legend Biotech Corp.-ADR Add +20.5% 15.67% −6.14